Carna Biosciences, Inc.

¥331.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:4572Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR (16.82%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.30
PE TTM —
TSR TTM 56.87%
Mkt cap ¥7.741B
ROIC (153.90%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥397
20.06%
(80.08%)
Buy 12|4|7|2|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
5.93
6.17
6.65
6.61
7.19%
3.50%
14.59%
8.45%
Revenue¥M
499.5
512.5
538.3
522.5
8.29%
7.93%
11.36%
8.59%
Peers (US$49.15M)
Cap (US$)
PE
54.11M
23.09x
45.38M
—
Capital
TTM
5Y
10Y
Leveragex
1.157
(0.152)
(0.093)
EBIT/Intx
4.336
0.070
0.071
Own earn%
(341.21)
2.94
20.53
Sh yield%
20.84
18.70
17.22
Owners
Insiders/Inst%
9.07
55.65
Short interest%
5.96
SBC / revenue%
4.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
8–16
$1 testx
—
Incr. ROIC%
2